A case of advanced prostate cancer controlled for the long term by flutamide after bicalutamide failure

Currently, the early introduction of new antiandrogens is popular for castration-resistant prostate cancer (CRPC). However, adverse events can be severe and their costs are high. Here, we present a patient with CRPC in whom flutamide controlled disease progression for 10 years. This case report show...

Descripción completa

Detalles Bibliográficos
Autores principales: Muramatsu, Tomoaki, Funahashi, Yasuhito, Yamamoto, Akiyuki, Sassa, Naoto, Matsukawa, Yoshihisa, Gotoh, Momokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892669/
https://www.ncbi.nlm.nih.gov/pubmed/31849389
http://dx.doi.org/10.18999/nagjms.81.4.707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892669/
https://www.ncbi.nlm.nih.gov/pubmed/31849389
http://dx.doi.org/10.18999/nagjms.81.4.707

Ejemplares similares